{"domain":"protagonist-inc.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"www.protagonist-inc.com","summary":"Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.","country":null,"country_source":"cdn","llms_txt":"https://www.protagonist-inc.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T12:57:08.223Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["biopharmaceutical","peptide drugs","rusfertide","clinical trials","drug pipeline"],"audience":"mixed","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":false,"agent_summary":"Protagonist Therapeutics: clinical-stage biopharma developing peptide-based drugs; pipeline, clinical trial news, and stock info.","llms_txt_cached":"https://agentwebmap.com/v1/domain/protagonist-inc.com/llms.txt","agentic":"documentation","section_keys":["blog-posts","pages"],"section_partial":false,"section_indexed_at":"2026-10-21T14:18:56.166Z"}